Netherlands / Government Expected To Decide On Pallas Financing In Q1 Of 2022, Says NRG

Company seeing increase in demand for medical isotopes for use in nuclear medicine therapy
Government Expected To Decide On Pallas Financing In Q1 Of 2022, Says NRG
The Petten research reactor site in the Netherlands. Courtesy NRG.
The Netherlands’ new government is expected to decide on the financing of the new Pallas research reactor planned for Petten in the first quarter of 2022, Nuclear Research & Consultancy Group (NRG) said.

NRG said the basic design of the new reactor, which will replace the 60-year-old high-flux reactor (HFR) at the site, is almost complete, after which the project will be ready for the construction phase.

In 2012, the Dutch government and the province of Noord-Holland decided that the HFR, which is operated by NRG, should be replaced to ensure the supply of medical isotopes and the continuation of nuclear research.

Want to keep reading?

Register free and get full access to NucNet for 14 days. No card required.

Republish or license this article

MORE THAN 30 YEARS OF NUCLEAR INDUSTRY REPORTING.

Subscribe for full access to every article, the archive and the SMR and AMR database.

Join NucNet